ERBB2 and breast cancer: JAC1 downregulates NEDD4-1 mRNA expression, thereby activating Smurf1-mediated proteasomal degradation of HER2 and inhibiting the proliferation of HER2-positive BC cells and tumor growth (Ren et al., 2021).